Clinical Trial Update: Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial comparing two doses of NVP (nevirapine) after initiating rifampin-containing TB therapy completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections
• Tuberculosis

Drugs mentioned

• NEVIRAPINE (nevirapine)

Snippet

Sponsor: The HIV Netherlands Australia Thailand Research Collaboration | Conditions: HIV Infections, Tuberculosis | Phase 2 | Status: COMPLETED